Catalyst Wire Dossier Catalyst Wire Dossier

NEXTSTELLIS

DROSPIRENONE AND ESTETROL · Mayne Pharma
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NEXTSTELLIS, covering 2021-04-15 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: NEXTSTELLIS — Supplemental Application (Mayne Pharma)

See pricing